Fibrox
Company

Last deal

Amount

Seed

Stage

12.07.2024

Date

1

all rounds

General

About Company
Fibrox develops innovative cell therapies based on fibroblasts and clinical requirements for patients.

Also Known As

Zhuyuan Medical Technology (Shanghai), Shiimoto Medicine, 椎元医学, Zhuiyuan Medical

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Fibrox develops innovative cell therapies based on fibroblasts and clinical requirements for patients.
Contacts